Ignite Creation Date:
2025-12-24 @ 1:06 PM
Ignite Modification Date:
2025-12-29 @ 4:46 AM
Study NCT ID:
NCT03126461
Status:
WITHDRAWN
Last Update Posted:
2020-08-20
First Post:
2017-03-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
SAbR Plus Ipilimumab Plus Nivolumab in Metastatic Melanoma Patients
Sponsor:
University of Texas Southwestern Medical Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
STU 082016-058
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None